North America Clinical Chemistry Market Development Trend Analysis Research to 2021

North America Clinical Chemistry Market Capacity, Generation, Size, Major

Feedstock, Regulations, and Key Country Analysis to 2021

Summary

GlobalData's new report, "North America Clinical Chemistry Market Outlook to 2021", provides

key market data on the North America Clinical Chemistry market. The report provides value, in

millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical

Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents,

Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category,

and global corporate-level profiles of the key market participants. Based on the availability of

data for the particular category and country, information related to pipeline products, news and

deals is available in the report.

Browse the full “Clinical Chemistry Market” report at:

http://www.radiantinsights.com/research/north-america-clinical-chemistry-marketoutlook-to-2021

Extensive interviews are conducted with industry experts to validate the market size, company

share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid

Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite

Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

- Annualized market revenues (USD million) data for each of the market categories. Data is

provided from 2007 to 2014 and forecast to 2021.

- 2014 company shares and distribution shares data for Clinical Chemistry market.

- Global corporate-level profiles of key companies operating within the North America Clinical

Chemistry market.

- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche

Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad

Laboratories, Inc.

Reasons to buy

-...